IDH1 Mutation as a Predictor of Glioma Progression

被引：0
|
作者：
Knobbe, C.
Nesrin, S.
von Deimling, A.
Mak, T. W.
Guha, A.
Croul, S. E.
机构：
[1] Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada
[2] Univ Toronto, Hosp Sick Children, Res Inst, Arthur & Sonia Labatts Brain Tumor Ctr, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Div Neurosurg, Toronto, ON M5S 1A1, Canada
[4] Univ Hlth Network Pathol, Toronto, ON, Canada
[5] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1623
引用
收藏
页码：382A / 382A
页数：1
相关论文
共 50 条
  • [31] Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment
    Trautwein, Christoph
    Zizmare, Laimdota
    Maurer, Irina
    Bender, Benjamin
    Bayer, Bjorn
    Ernemann, Ulrike
    Tatagiba, Marcos
    Grau, Stefan J.
    Pichler, Bernd J.
    Skardelly, Marco
    Tabatabai, Ghazaleh
    JCI INSIGHT, 2022, 7 (03)
  • [32] IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
    Xueqin Chen
    Jun Liu
    Yuqin Li
    Yuequan Zeng
    Fang Wang
    Zexiong Cheng
    Hao Duan
    Guopeng Pan
    Shangqi Yang
    Yuling Chen
    Qing Li
    Xi Shen
    Ying Li
    Zixi Qin
    Jiahong Chen
    Youwei Huang
    Xiangyu Wang
    Yuli Lu
    Minfeng Shu
    Yubo Zhang
    Guocai Wang
    Kai Li
    Xi Lin
    Fan Xing
    Haipeng Zhang
    Nature Communications, 14
  • [33] Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
    Dana A N Mustafa
    Sigrid M Swagemakers
    Laura Buise
    Peter J van der Spek
    Johan M Kros
    Acta Neuropathologica Communications, 2
  • [34] Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
    Mustafa, Dana A. N.
    Swagemakers, Sigrid M.
    Buise, Laura
    van der Spek, Peter J.
    Kros, Johan M.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [35] Rapid IDH1/IDH2 Mutation Assessment in Acute Myeloid Leukemia (AML) and Glioma
    Huynh, T.
    Zhang, L.
    Li, Y.
    Solis, J.
    Stanley, A.
    Jin, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S163 - S164
  • [36] Metabolism of glioma and IDH1/IDH2 mutations
    Rossetto, M.
    Ciccarino, P.
    Boisselier, B.
    Labussiere, M.
    Sanson, M.
    REVUE NEUROLOGIQUE, 2011, 167 (10) : 699 - 703
  • [37] Discovery of Novel Dual Inhibitors Targeting Mutant IDH1 and NAMPT for the Treatment of Glioma with IDH1Mutation
    Wen, Fei
    Gui, Gang
    Wang, Xiaoyu
    Qin, Anqi
    Ma, Tianfang
    Chen, Hui
    Li, Chunzheng
    Zha, Xiaoming
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 8667 - 8692
  • [38] An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
    Lewandowska, Marzena Anna
    Furtak, Jacek
    Szylberg, Tadeusz
    Roszkowski, Krzysztof
    Windorbska, Wieslawa
    Rytlewska, Joanna
    Jozwicki, Wojciech
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (01) : 45 - 53
  • [39] Mutant IDH1 and seizures in patients with glioma
    Chen, Hao
    Judkins, Jonathon
    Thomas, Cheddhi
    Wu, Meijing
    Khoury, Laith
    Benjamin, Carolina G.
    Pacione, Donato
    Golfinos, John G.
    Kumthekar, Priya
    Ghamsari, Farhad
    Chen, Li
    Lein, Pamela
    Chetkovich, Dane M.
    Snuderl, Matija
    Horbinski, Craig
    NEUROLOGY, 2017, 88 (19) : 1805 - 1813
  • [40] TEXTILOMA RESEMBLING ANAPLASTIC PROGRESSION OF AN IDH1 MUTANT, LOW-GRADE GLIOMA
    Anderson, Mark D.
    Raghunathan, Aditya
    Aldape, Kenneth D.
    Fuller, Greg N.
    Gilbert, Mark R.
    NEURO-ONCOLOGY, 2012, 14 : 67 - 67
12345